Preclinical Evaluation of a Growth‐Accommodating Transcatheter Pulmonary Valve System for Young Children
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.041932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Nnaoma Agwu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering University of California Irvine CA USA. Hauptthemen laut MEDLINE: Pulmonary Valve, Cardiac Catheterization, Pulmonary Valve Insufficiency, Heart Valve Prosthesis. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NICHD NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Congenital heart defects affect approximately 1% of births in the United States and Europe, with >1 million children in the United States living with congenital heart defects. Many experience abnormalities in the right ventricular outflow tract, often necessitating surgical intervention early in life. However, the initial repairs typically are temporary solutions as many patients will eventually need pulmonary valve replacement to address pulmonary valve regurgitation and prevent right ventricle failure. Addressing progressive pulmonary valve regurgitation, ideally in patients weighing 8 to 10 kg, is critical to prevent right ventricle dysfunction. Transcatheter pulmonary valve replacement currently treats patients weighing at least 20 kg. Unfortunately, smaller children must wait for valve replacement and risk right ventricular dilation.
Methods
To address this challenge, we have developed the IRIS Valve, a growth‐accommodating transcatheter pulmonary heart valve inspired by origami targeting implantation in at least 8 kg children. The valve stent underwent finite element analysis with validation by fracture testing. Using a 12‐Fr transcatheter system, the IRIS valve was implanted into 8 to 17 kg Yucatan mini pigs for 6 months.
Results
Benchtop fracture testing and finite element analysis confirmed the stent's ability to be crimped to a 3‐mm diameter for loading into a 12‐Fr transcatheter system and expanded to 20 mm without fracture. Animal studies successfully demonstrated excellent integration within the pulmonary valve annulus, intact valve integrity, and favorable tissue response.
Conclusions
The IRIS Valve offers a promising solution for earlier treatment of heart valve disease in pediatric patients with congenital heart defects, potentially improving outcomes in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering University of California Irvine CA USA.
- Children's Hospital of Orange County Orange CA USA.
- Department of Radiological Sciences University of California Irvine CA USA.
ORCID-Profile: Nnaoma Agwu, Daryl Chau, Michael R Recto, Arash Kheradvar
Förderung
- NHLBI NIH HHS
- NICHD NIH HHS
Zitieren
APA
Agwu, N., Chau, D., Kelley, G. S., Burney, T., Perminov, E., Alcantara, C., Recto, M. R., & Kheradvar, A. (2025). Preclinical Evaluation of a Growth‐Accommodating Transcatheter Pulmonary Valve System for Young Children. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.041932
Vancouver
Agwu N, Chau D, Kelley GS, Burney T, Perminov E, Alcantara C, et al. Preclinical Evaluation of a Growth‐Accommodating Transcatheter Pulmonary Valve System for Young Children. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.041932
BibTeX
@article{Agwu2025,
author = {Agwu, Nnaoma and Chau, Daryl and Kelley, Gregory S and Burney, Tanya and Perminov, Ekaterina and Alcantara, Christopher and Recto, Michael R and Kheradvar, Arash},
title = {Preclinical Evaluation of a Growth‐Accommodating Transcatheter Pulmonary Valve System for Young Children},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.041932}
}
EUVIMED